VC investors optimistic about 2014 biotech prospects
This article was originally published in Scrip
Executive Summary
A rise in initial public offerings by biotechnology companies doesn't automatically lead to increased investment by venture capital firms that finance drug development startups, but venture funders are optimistic about the life science industry's prospects in 2014.